The role of b-type natriuretic peptide in heart failure management

Summary. Heart failure is a complex clinical syndrome that manifests itself with signs and symptoms which are neither sensitive nor specific for the diagnosis of heart failure. Natriuretic peptides and in particular b-type natriuretic peptide (and nt-proBNP) are widely used in clinical practice aro...

Full description

Bibliographic Details
Main Authors: Newton, Phillip, Betihavas, Vasiliki, Macdonald, P.
Format: Journal Article
Published: Elsevier Inc 2009
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/14305
_version_ 1848748588179390464
author Newton, Phillip
Betihavas, Vasiliki
Macdonald, P.
author_facet Newton, Phillip
Betihavas, Vasiliki
Macdonald, P.
author_sort Newton, Phillip
building Curtin Institutional Repository
collection Online Access
description Summary. Heart failure is a complex clinical syndrome that manifests itself with signs and symptoms which are neither sensitive nor specific for the diagnosis of heart failure. Natriuretic peptides and in particular b-type natriuretic peptide (and nt-proBNP) are widely used in clinical practice around the world as a maker of heart failure. BNP is primarly released from the left ventricle in response to pressure and volume overload. The strongest evidence for the use of BNP is to rule in or rule out heart failure as cause of breathlessness in people who present to the emergency room. There is enthusiasm for use of BNP as a market of heart failure severity as well as a predictor of outcomes in people with heart failure and trials are ongoing. Nesiritide, a recombinant form of BNP is currently being tested as a possible treatment in people with acutely decompensated heart failure.
first_indexed 2025-11-14T07:07:25Z
format Journal Article
id curtin-20.500.11937-14305
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:07:25Z
publishDate 2009
publisher Elsevier Inc
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-143052017-09-13T15:54:08Z The role of b-type natriuretic peptide in heart failure management Newton, Phillip Betihavas, Vasiliki Macdonald, P. Heart failure peptide b-Type natriuretic Summary. Heart failure is a complex clinical syndrome that manifests itself with signs and symptoms which are neither sensitive nor specific for the diagnosis of heart failure. Natriuretic peptides and in particular b-type natriuretic peptide (and nt-proBNP) are widely used in clinical practice around the world as a maker of heart failure. BNP is primarly released from the left ventricle in response to pressure and volume overload. The strongest evidence for the use of BNP is to rule in or rule out heart failure as cause of breathlessness in people who present to the emergency room. There is enthusiasm for use of BNP as a market of heart failure severity as well as a predictor of outcomes in people with heart failure and trials are ongoing. Nesiritide, a recombinant form of BNP is currently being tested as a possible treatment in people with acutely decompensated heart failure. 2009 Journal Article http://hdl.handle.net/20.500.11937/14305 10.1016/j.aucc.2009.06.001 Elsevier Inc fulltext
spellingShingle Heart failure
peptide
b-Type natriuretic
Newton, Phillip
Betihavas, Vasiliki
Macdonald, P.
The role of b-type natriuretic peptide in heart failure management
title The role of b-type natriuretic peptide in heart failure management
title_full The role of b-type natriuretic peptide in heart failure management
title_fullStr The role of b-type natriuretic peptide in heart failure management
title_full_unstemmed The role of b-type natriuretic peptide in heart failure management
title_short The role of b-type natriuretic peptide in heart failure management
title_sort role of b-type natriuretic peptide in heart failure management
topic Heart failure
peptide
b-Type natriuretic
url http://hdl.handle.net/20.500.11937/14305